BioMerieux SA (XPAR:BIM)
€ 99.3 0.05 (0.05%) Market Cap: 11.73 Bil Enterprise Value: 11.90 Bil PE Ratio: 32.99 PB Ratio: 3.13 GF Score: 98/100

Q3 2023 Biomerieux SA Corporate Sales Call Transcript

Oct 26, 2023 / 01:00PM GMT
Release Date Price: €86.66 (-1.16%)
Operator

Good day, and welcome to the bioMérieux Third Quarter 2023 Sales Release Conference Call. Today's conference is being recorded.

At this time, I'd like to turn the conference over to Aymeric Fichet. Please go ahead.

Aymeric Fichet

Thank you. Good afternoon, everyone, and thank you for joining us to review bioMérieux performance for the third quarter of 2023.

I am online with Pierre Boulud, CEO; as well as Guillaume Bouhours, CFO.

Before handing the call over to Pierre for preliminary remarks, please note that this conference call will include forward-looking statements that may change or be modified due to uncertainties and risks related to the company's environment. Accordingly, we cannot give any assurance as to whether we will achieve these objectives.

I also remind you that today's call is being recorded and that a replay will be available on our website, www.biomerieux-finance.com.

I will now hand the call over to Pierre, and then we will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot